Artimplant continues to realign its organization to the market - annual savings of approximately SEK 5 million

Artimplant continues to realign its organization to the market - annual
savings of approximately SEK 5 million

Västra Frölunda, Sweden, August 23, 2010

Artimplant is following through on its strategy of focusing the company
on the market even further and has now concluded negotiations under the
Swedish Co-Determination Act, resulting in staff cutbacks within
functions not related directly to sales. Once the periods of notice have
been completed the annual saving at Artimplant AB will be approximately
SEK 5 million.

Artimplant has concluded negotiations under the Co-Determination Act and
the company's new proposed organization has been accepted by the staff
and trade unions concerned. This will result in staff cutbacks in areas
not related directly to sales. The cost of the reorganization is related
purely to the periods of notice, which vary from two to six months. Once
all the periods of notice have been completed, there will be an annual
saving of approximately SEK 5 million.

Artimplant CEO Hans Rosén states: "I'm extremely proud of Artimplant's
employees, who have to a man supported the change in strategy and the
reorganization that are being implemented. As the parties involved in
negotiations under the Co-Determination Act have accepted Artimplant's
proposed reorganization, there will be no extra restructuring costs,
which will have a positive impact on the company's capital requirements.
The reorganization will free up resources for use within an expanded
sales organization, which will focus on the key US market.”

For further information, please contact: Hans Rosén, CEO, phone 46
(0)31-746 56 00, 46 (0)708 58 34 70,
hans.rosen@artimplant.com (hans.rosen@artimplant.com)

Lars-Johan Cederbrant, CFO, phone 46 (0)31-746 56 54, 46 (0)703 01 68
54,
lars-johan.cederbrant@artimplant.com (lars-johan.cederbrant@artimplant.c
om)

Further information is available at
www.artimplant.com (http://www.artimplant.com). To subscribe to future
press releases please go to
www.artimplant.com/investors-media/subscribe-to-press-releases.html (htt
p://www.artimplant.com/investors-media/subscribe-to-press-releases.html)